![David Eric Kroin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Eric Kroin
Directeur Général chez
Deep Track Capital LP
Profil
Mr. David E.
Kroin is a Founder & Chief Investment Officer at Deep Track Capital LP.
He is on the Board of Directors at CorEvitas LLC.
He has over 23 years of investing experience in the healthcare industry.
Prior to founding Deep Track Capital, David co-founded Great Point Partners in 2003 and was the co-portfolio manager for its equity long/short biotechnology hedge fund as well as an investment committee member for Great Point’s private equity funds investing in recaps and buyouts of health care companies.
Mr. Kroin earned a Bachelor of Science in Actuarial Mathematics from the University of Michigan and serves on the leadership council of the University’s Life Sciences Institute.
He has served on numerous boards of public and private health care companies (including, CellCarta, Cytovance, CorEvitas, Mediatech, ProPT, Biodel, APT, Gentium and US Bioservices).
Postes actifs de David Eric Kroin
| Sociétés | Poste | Début |
|---|---|---|
CorEvitas LLC
 CorEvitas LLC BiotechnologyHealth Technology Operates as a science-led, real-world data intelligence company | Directeur/Membre du Conseil | - |
Deep Track Capital LP
 Deep Track Capital LP Investment ManagersFinance Provides investment advice | Directeur Général | 29/04/2020 |
Anciens postes connus de David Eric Kroin
| Sociétés | Poste | Fin |
|---|---|---|
Great Point Partners Private Equity
 Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Fondateur | 30/09/2020 |
Great Point Partners LLC
 Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Fondateur | 01/09/2020 |
| CONNECTURE INC | Directeur/Membre du Conseil | 01/08/2014 |
Health Revenue Assurance Holdings, Inc.
 Health Revenue Assurance Holdings, Inc. Services to the Health IndustryHealth Services Provides revenue integrity technology and services for healthcare organizations | Directeur/Membre du Conseil | 04/04/2014 |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | 02/06/2010 |
Formation de David Eric Kroin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Great Point Partners LLC
Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Finance |
Connecture, Inc.
 Connecture, Inc. Internet Software/ServicesTechnology Services Provides web-based sales and service automation solutions to the health insurance industry | Technology Services |
J.H. Whitney Capital Partners, LLC
 J.H. Whitney Capital Partners, LLC Investment ManagersFinance Alternative investment manager | Finance |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Manufactures and develops biopharmaceutical products for cancer treatments & vascular diseases | Health Technology |
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
US Bioservices Corp.
 US Bioservices Corp. Pharmaceuticals: MajorHealth Technology Distributes pharmaceutical products and services | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ICON International, Inc.
 ICON International, Inc. Investment Banks/BrokersFinance Provides corporate barter and financial transaction services | Finance |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Commercial Services |
Great Point Partners Private Equity
Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Finance |
Risk Services LLC
 Risk Services LLC Insurance Brokers/ServicesFinance Provides insurance and risk management solutions | Finance |
Health Revenue Assurance Holdings, Inc.
Health Revenue Assurance Holdings, Inc. Services to the Health IndustryHealth Services Provides revenue integrity technology and services for healthcare organizations | Health Services |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
CorEvitas LLC
CorEvitas LLC BiotechnologyHealth Technology Operates as a science-led, real-world data intelligence company | Health Technology |
Deep Track Capital LP
Deep Track Capital LP Investment ManagersFinance Provides investment advice | Finance |
